Local drug delivery for oral mucosal diseases: challenges and opportunities

Nanotechnology systems for oral drug delivery: challenges and opportunities

Poly (Lactic Acid)Nanofibres as Drug Delivery Systems: Opportunities and Challenges

Numerous Scientists have discovered the procedure of nanotechnology, explicitlynanofibers, asdrug delivery systems for transdermal uses. Nanofibers canbe used to deliver drugs and are capable of controlled release for a continued periodof time. Poly (Lactic Acid) (PLA) is the lastly interesting employed synthetic polymer in biomedical application owing to its well categorized biodegradable prop...

Nanophase Ceramics for Improved Drug Delivery: Current Opportunities and Challenges

Introduction After more than a decade of research and development, nanotechnology has reshaped the traditional thinking (or lack thereof) of using ceramics for drug delivery. Although drug delivery has been a polymer-dominated field, the blossoming of nanotechnology means that ceramic materials are now showing much promise for numerous drug delivery applications. Typically, nanotechnology is de...

Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery

This review highlights the characteristics of the cancer that provide opportunities for drug delivery carriers to target cancer. These opportunities include EPR effect, high interstitial pressure of tumour, low pH of endosomes of tumor cells, overexpressed receptors, angiogenesis etc. Chemotherapy is one of the most important treatments currently available among the various approaches. The pres...

Kidney-Specific Drug Delivery: Review of Opportunities, Achievements, and Challenges

Kidneys are involved in essential complex procedures that maintain the body in equilibrium and preservethe interior environment necessary for life. Nephritis and nephrosis were ranked among the leading causes of death in all ages in the last global burden of disease assessment of the World Health Organization (WHO). Regarding kidney disease therapeutics, the unfavourable extra-target effects, t...